Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cannabis Science Inc announces United States Federal Government approval of university study of medical Cannabis for Veterans Suffering from PTSD


Wednesday, 19 Mar 2014 10:03am EDT 

Cannabis Science Inc:Approval of University of Arizona study of efficacy of medical cannabis in treating post traumatic stress disorder (PTSD).Cannabis Science sees this approval by U.S. Department of Health and Human Services as watershed moment for federal authorization of medical cannabis research. 

Company Quote

0.0753
 --
29 Oct 2014